These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 37888087)

  • 21. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
    Grills IS; Kestin LL; Goldstein N; Mitchell C; Martinez A; Ingold J; Vicini FA
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):658-70. PubMed ID: 12788171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of axillary lymph node metastasis in primary breast cancer.
    Jatoi I; Hilsenbeck SG; Clark GM; Osborne CK
    J Clin Oncol; 1999 Aug; 17(8):2334-40. PubMed ID: 10561295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does Alternative and Traditional WASAM (Local cautery) Therapy Facilitate an Early and More Extensive Locoregional Metastasis of Breast Cancer?
    Department of Surgery and National Oncology Center, The Royal Hospital Muscat, Sultanate of Oman
    Gulf J Oncolog; 2016 Sep; 1(22):37-42. PubMed ID: 28191804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time-varying effects of prognostic factors associated with long-term survival in breast cancer.
    Zhang M; Peng P; Gu K; Cai H; Qin G; Shu XO; Bao P
    Endocr Relat Cancer; 2018 May; 25(5):509-521. PubMed ID: 29472247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer.
    Takei H; Suemasu K; Kurosumi M; Horii Y; Yoshida T; Ninomiya J; Yoshida M; Hagiwara Y; Kamimura M; Hayashi Y; Inoue K; Tabei T
    Breast Cancer; 2007; 14(1):16-24. PubMed ID: 17244989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer.
    Sjöström-Mattson J; Von Boguslawski K; Bengtsson NO; Mjaaland I; Salmenkivi K; Blomqvist C
    Acta Oncol; 2009; 48(8):1137-43. PubMed ID: 19863221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variability of oestrogen and progesterone receptor status between primary breast cancer and nodal metastases: preliminary communication.
    Fernandez D; Sauven P; Alaghband-Zadeh J; Burn JI
    J R Soc Med; 1982 Sep; 75(9):719-22. PubMed ID: 7120257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma.
    Zekioglu O; Erhan Y; Ciris M; Bayramoglu H; Ozdemir N
    Histopathology; 2004 Jan; 44(1):18-23. PubMed ID: 14717664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spatial intratumoural heterogeneity in the expression of GIT1 is associated with poor prognostic outcome in oestrogen receptor positive breast cancer patients with synchronous lymph node metastases.
    Goicoechea I; Rezola R; Arestin M; M Caffarel M; Cortazar AR; Manterola L; Fernandez-Mercado M; Armesto M; Sole C; Larrea E; M Araujo A; Ancizar N; Plazaola A; Urruticoechea A; Carracedo A; Ruiz I; Alvarez Lopez I; H Lawrie C
    F1000Res; 2017; 6():1606. PubMed ID: 29862012
    [No Abstract]   [Full Text] [Related]  

  • 30. Genomic comparison of paired primary breast carcinomas and lymph node macrometastases using the Oncotype DX Breast Recurrence Score
    Boolbol SK; Harshan M; Chadha M; Kirstein L; Cohen JM; Klein P; Anderson J; Davison D; Jakubowski DM; Baehner FL; Malamud S
    Breast Cancer Res Treat; 2019 Oct; 177(3):611-618. PubMed ID: 31302854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis.
    Rosin G; de Boniface J; Karthik GM; Frisell J; Bergh J; Hartman J
    Br J Cancer; 2014 Aug; 111(5):918-26. PubMed ID: 25025959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphometry and breast cancer. II. Characterisation of breast cancer cells with high malignant potential in patients with spread to lymph nodes: preliminary results.
    van der Linden HC; Baak JP; Lindeman J; Hermans J; Meyer CJ
    J Clin Pathol; 1986 Jun; 39(6):603-9. PubMed ID: 3722413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oestrogen receptors and primary breast cancer.
    Humeniuk V; Hawkins RA; Prescott RJ; Roberts MM; Stewart HJ; Forrest AP
    Aust N Z J Surg; 1982 Aug; 52(4):408-14. PubMed ID: 6956318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer.
    Truong PT; Vinh-Hung V; Cserni G; Woodward WA; Tai P; Vlastos G;
    Eur J Cancer; 2008 Aug; 44(12):1670-7. PubMed ID: 18595686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer.
    Sopik V; Narod SA
    Breast Cancer Res Treat; 2018 Aug; 170(3):647-656. PubMed ID: 29693227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.
    Van Calster B; Vanden Bempt I; Drijkoningen M; Pochet N; Cheng J; Van Huffel S; Hendrickx W; Decock J; Huang HJ; Leunen K; Amant F; Berteloot P; Paridaens R; Wildiers H; Van Limbergen E; Weltens C; Timmerman D; Van Gorp T; Smeets A; Van den Bogaert W; Vergote I; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2009 Jan; 113(1):181-7. PubMed ID: 18264760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapy.
    Alkner S; Ehinger A; Bendahl PO; Rydén L; Fernö M
    Eur J Cancer; 2015 Nov; 51(16):2304-13. PubMed ID: 26243193
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.